Landen et al. demonstrated that in an orthotopic ovarian cancer mouse model, ALDH1A1 silencing by siRNA sensitized both paclitaxel- and carboplatin-resistant cell lines to chemotherapy and inhibited tumor growth significantly. Here, ALDH1A1 is linked to ovarian cancer.